Loading...
Innospec Inc.
IOSP•NASDAQ
Basic Materials
Chemicals - Specialty
$84.38
$0.20(0.24%)
Innospec Inc. (IOSP) Financial Performance & Income Statement Overview
Review Innospec Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-5.31%
↓ 5.31%
Operating Income Growth
10.09%
↑ 10.09%
Net Income Growth
-74.41%
↓ 74.41%
Operating Cash Flow Growth
-11.00%
↓ 11.00%
Operating Margin
9.55%
↑ 9.55%
Gross Margin
28.68%
↑ 28.68%
Net Profit Margin
1.51%
↑ 1.51%
ROE
2.96%
↑ 2.96%
ROIC
9.61%
↑ 9.61%
Innospec Inc. (IOSP) Income Statement & Financial Overview
Review Innospec Inc.'s (IOSP) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $466.80M | $443.40M | $435.00M | $500.20M |
| Cost of Revenue | $330.60M | $319.30M | $308.10M | $344.50M |
| Gross Profit | $136.20M | $124.10M | $126.90M | $155.70M |
| Gross Profit Ratio | $0.29 | $0.28 | $0.29 | $0.31 |
| R&D Expenses | $12.70M | $11.10M | $12.20M | $11.80M |
| SG&A Expenses | $81.10M | $66.80M | $73.40M | $92.70M |
| Operating Expenses | $93.80M | $77.90M | $85.60M | $104.50M |
| Total Costs & Expenses | $424.40M | $397.20M | $393.70M | $449.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $2.10M |
| Interest Expense | $0.00 | $0.00 | $2.10M | $0.00 |
| Depreciation & Amortization | $3.70M | $11.10M | $11.10M | $10.40M |
| EBITDA | $41.10M | $55.90M | $54.80M | $63.30M |
| EBITDA Ratio | $0.09 | $0.13 | $0.13 | $0.13 |
| Operating Income | $41.10M | $45.60M | $41.30M | $51.20M |
| Operating Income Ratio | $0.09 | $0.10 | $0.09 | $0.10 |
| Other Income/Expenses (Net) | -$143.70M | -$800000.00 | $2.40M | $2.40M |
| Income Before Tax | -$102.60M | $44.80M | $43.70M | $55.30M |
| Income Before Tax Ratio | -$0.22 | $0.10 | $0.10 | $0.11 |
| Income Tax Expense | -$32.20M | $11.40M | $12.50M | $13.90M |
| Net Income | -$70.40M | $33.40M | $31.20M | $41.40M |
| Net Income Ratio | -$0.15 | $0.08 | $0.07 | $0.08 |
| EPS | -$2.82 | $1.34 | $1.25 | $1.66 |
| Diluted EPS | -$2.80 | $1.33 | $1.24 | $1.65 |
| Weighted Avg Shares Outstanding | $24.95M | $24.94M | $24.94M | $24.89M |
| Weighted Avg Shares Outstanding (Diluted) | $24.95M | $25.10M | $25.10M | $25.07M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan